Table 1.

Reanalysis of data

Ibrutinib doseORR (%)CR (%)DLT (%)
280 8/10 (80) 5/10 (50) 0/10 (0) 
420 18/20 (90) 8/19 (42) 3/21 (14) 
Ibrutinib doseORR (%)CR (%)DLT (%)
280 8/10 (80) 5/10 (50) 0/10 (0) 
420 18/20 (90) 8/19 (42) 3/21 (14) 

Data are from Table 1 of Portell et al.10 

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal